OS Therapies amends private placement terms with Leonite; dilutive adjustment delayed to Sept 30, 2026

OS Therapies Inc

Side letter modifies anti-dilution provisions in $10M convertible note and warrant.
Dilutive issuance adjustments under Note and Warrant will not become effective until September 30, 2026.
Carve-out for offerings of at least $5M gross proceeds now requires single closing, not aggregated tranches.
Agreement dated June 30, 2026 between OS Therapies and Leonite Fund I, LP.
No other changes to transaction documents.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.